Chinese General Practice ›› 2022, Vol. 25 ›› Issue (27): 3384-3389.DOI: 10.12114/j.issn.1007-9572.2022.0269
• Article • Previous Articles Next Articles
Received:
2022-03-05
Revised:
2022-05-10
Published:
2022-09-20
Online:
2022-06-23
Contact:
Zhen YU
About author:
通讯作者:
玉珍
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0269
组别 | 例数 | 胎龄( | 出生体质量( | 入院出生时间〔M(Q1,Q3),h〕 | SGA〔n( %)〕 | RDS 3~4级〔n( %)〕 | 生后Apgar评分〔M(Q1,Q3),分〕 | ||
---|---|---|---|---|---|---|---|---|---|
1 min | 5 min | 10 min | |||||||
INSURE组 | 122 | 32(30,33) | 1 505.1±384.8 | 0.5(0.5,1.0) | 55(45.1) | 24(19.7) | 9(7,10) | 10(9,10) | 10(9,10) |
MV组 | 61 | 30(29,32) | 1 342.4±523.9 | 0.5(0.5,1.0) | 26(42.6) | 10(16.4) | 6(3,9) | 8(6,10) | 9(7,10) |
检验统计量值 | -2.926b | 2.152b | -1.463 | 0.100a | 0.289a | -3.888 | -4.575 | -3.913 | |
P值 | 0.003 | 0.034 | 0.143 | 0.752 | 0.591 | <0.001 | <0.001 | <0.001 | |
组别 | 胎位异常〔n(%)〕 | 脐带异常〔n(%)〕 | 胎心异常〔n(%)〕 | 胎盘异常〔n(%)〕 | 羊水污染〔n(%)〕 | 宫内窘迫〔n(%)〕 | 母亲年龄( | 母亲长期居住地海拔高度〔M(Q1,Q3),m〕 | 母亲产检次数〔M(Q1,Q3),次〕 |
INSURE组 | 8(6.6) | 16(13.1) | 21(17.2) | 17(13.9) | 14(11.5) | 29(23.8) | 29.8±5.8 | 3 903.0(3 651.0,4 300.0) | 5(4,7) |
MV组 | 6(9.8) | 9(14.8) | 10(16.4) | 5(8.2) | 13(21.3) | 12(19.7) | 30.3±5.6 | 3 800.0(3 651.0,4 150.0) | 5(4,7) |
检验统计量值 | 0.619a | 0.093a | 0.019a | 1.266a | 3.128a | 0.393a | 0.517b | -1.525 | -0.131 |
P值 | 0.432 | 0.761 | 0.889 | 0.261 | 0.077 | 0.531 | 0.606 | 0.127 | 0.896 |
组别 | 母亲剖宫产率〔n(%)〕 | 母亲异常分娩率〔n(%)〕 | 母亲为农牧民〔n(%)〕 | 母亲产前糖皮质激素治疗〔n(%)〕 | 母亲不良孕产史〔n(%)〕 | 母亲ICP〔n(%)〕 | 母亲胎膜早破〔n(%)〕 | 母亲妊娠期高血压〔n(%)〕 | 母亲产前感染〔n(%)〕 |
INSURE组 | 70(57.4) | 9(7.4) | 63(51.6) | 7(5.7) | 42(34.4) | 11(9.1) | 16(13.1) | 63(51.6) | 5(4.1) |
MV组 | 33(54.1) | 2(3.3) | 37(60.7) | 10(16.4) | 23(37.7) | 7(11.5) | 13(21.3) | 28(45.9) | 2(3.3) |
检验统计量值 | 0.178a | 0.592a | 1.334a | 5.480a | 0.191a | 0.277a | 2.049a | 0.536a | 0.074c |
P值 | 0.673 | 0.441 | 0.248 | 0.019 | 0.662 | 0.598 | 0.152 | 0.464 | 1.000 |
Table 1 Comparison of clinical data of two groups of RDS premature infants
组别 | 例数 | 胎龄( | 出生体质量( | 入院出生时间〔M(Q1,Q3),h〕 | SGA〔n( %)〕 | RDS 3~4级〔n( %)〕 | 生后Apgar评分〔M(Q1,Q3),分〕 | ||
---|---|---|---|---|---|---|---|---|---|
1 min | 5 min | 10 min | |||||||
INSURE组 | 122 | 32(30,33) | 1 505.1±384.8 | 0.5(0.5,1.0) | 55(45.1) | 24(19.7) | 9(7,10) | 10(9,10) | 10(9,10) |
MV组 | 61 | 30(29,32) | 1 342.4±523.9 | 0.5(0.5,1.0) | 26(42.6) | 10(16.4) | 6(3,9) | 8(6,10) | 9(7,10) |
检验统计量值 | -2.926b | 2.152b | -1.463 | 0.100a | 0.289a | -3.888 | -4.575 | -3.913 | |
P值 | 0.003 | 0.034 | 0.143 | 0.752 | 0.591 | <0.001 | <0.001 | <0.001 | |
组别 | 胎位异常〔n(%)〕 | 脐带异常〔n(%)〕 | 胎心异常〔n(%)〕 | 胎盘异常〔n(%)〕 | 羊水污染〔n(%)〕 | 宫内窘迫〔n(%)〕 | 母亲年龄( | 母亲长期居住地海拔高度〔M(Q1,Q3),m〕 | 母亲产检次数〔M(Q1,Q3),次〕 |
INSURE组 | 8(6.6) | 16(13.1) | 21(17.2) | 17(13.9) | 14(11.5) | 29(23.8) | 29.8±5.8 | 3 903.0(3 651.0,4 300.0) | 5(4,7) |
MV组 | 6(9.8) | 9(14.8) | 10(16.4) | 5(8.2) | 13(21.3) | 12(19.7) | 30.3±5.6 | 3 800.0(3 651.0,4 150.0) | 5(4,7) |
检验统计量值 | 0.619a | 0.093a | 0.019a | 1.266a | 3.128a | 0.393a | 0.517b | -1.525 | -0.131 |
P值 | 0.432 | 0.761 | 0.889 | 0.261 | 0.077 | 0.531 | 0.606 | 0.127 | 0.896 |
组别 | 母亲剖宫产率〔n(%)〕 | 母亲异常分娩率〔n(%)〕 | 母亲为农牧民〔n(%)〕 | 母亲产前糖皮质激素治疗〔n(%)〕 | 母亲不良孕产史〔n(%)〕 | 母亲ICP〔n(%)〕 | 母亲胎膜早破〔n(%)〕 | 母亲妊娠期高血压〔n(%)〕 | 母亲产前感染〔n(%)〕 |
INSURE组 | 70(57.4) | 9(7.4) | 63(51.6) | 7(5.7) | 42(34.4) | 11(9.1) | 16(13.1) | 63(51.6) | 5(4.1) |
MV组 | 33(54.1) | 2(3.3) | 37(60.7) | 10(16.4) | 23(37.7) | 7(11.5) | 13(21.3) | 28(45.9) | 2(3.3) |
检验统计量值 | 0.178a | 0.592a | 1.334a | 5.480a | 0.191a | 0.277a | 2.049a | 0.536a | 0.074c |
P值 | 0.673 | 0.441 | 0.248 | 0.019 | 0.662 | 0.598 | 0.152 | 0.464 | 1.000 |
组别 | 例数 | 不同胎龄 | ||
---|---|---|---|---|
<29周 | 29~32周 | 33~36+6周 | ||
INSURE组 | 122 | 8(6.6) | 74(60.7) | 40(32.8) |
MV组 | 61 | 13(21.3) | 35(57.4) | 13(21.3) |
χ2值 | 9.637 | |||
P值 | 0.008 |
Table 2 Comparison of the composition of premature infants of different gestational ages between two groups
组别 | 例数 | 不同胎龄 | ||
---|---|---|---|---|
<29周 | 29~32周 | 33~36+6周 | ||
INSURE组 | 122 | 8(6.6) | 74(60.7) | 40(32.8) |
MV组 | 61 | 13(21.3) | 35(57.4) | 13(21.3) |
χ2值 | 9.637 | |||
P值 | 0.008 |
组别 | 例数 | 5 min Apgar评分 | ||
---|---|---|---|---|
≤5分 | 6~7分 | 8~10分 | ||
INSURE组 | 122 | 1(0.8) | 9(7.4) | 112(91.8) |
MV组 | 61 | 9(3.3) | 10(16.4) | 42(68.9) |
χ2值 | 18.991 | |||
P值 | <0.001 |
Table 3 Comparison of the composition of premature infants of different 5 min Apgar score between two groups
组别 | 例数 | 5 min Apgar评分 | ||
---|---|---|---|---|
≤5分 | 6~7分 | 8~10分 | ||
INSURE组 | 122 | 1(0.8) | 9(7.4) | 112(91.8) |
MV组 | 61 | 9(3.3) | 10(16.4) | 42(68.9) |
χ2值 | 18.991 | |||
P值 | <0.001 |
组别 | 例数 | BPD〔n(%)〕 | 肺出血〔n(%)〕 | 气胸〔n(%)〕 | 颅内出血〔n(%)〕 | 第2剂PS〔n(%)〕 | 住院天数〔M(Q1,Q3),d〕 | 死亡〔n(%)〕 |
---|---|---|---|---|---|---|---|---|
INSURE组 | 122 | 18(14.8) | 8(6.6) | 6(4.9) | 23(18.9) | 1(0.8) | 27(15,42) | 10(8.2) |
MV组 | 61 | 16(26.2) | 15(24.6) | 4(6.6) | 7(11.5) | 3(4.9) | 31(4,46) | 24(39.3) |
χ2(Z)值 | 3.540 | 12.034 | 0.212 | 1.615 | 3.195 | -0.157a | 26.081 | |
P值 | 0.060 | 0.001 | 0.733 | 0.289 | 0.109 | 0.875 | <0.001 |
Table 4 Comparison of complications and outcomes between two groups of RDS premature infants
组别 | 例数 | BPD〔n(%)〕 | 肺出血〔n(%)〕 | 气胸〔n(%)〕 | 颅内出血〔n(%)〕 | 第2剂PS〔n(%)〕 | 住院天数〔M(Q1,Q3),d〕 | 死亡〔n(%)〕 |
---|---|---|---|---|---|---|---|---|
INSURE组 | 122 | 18(14.8) | 8(6.6) | 6(4.9) | 23(18.9) | 1(0.8) | 27(15,42) | 10(8.2) |
MV组 | 61 | 16(26.2) | 15(24.6) | 4(6.6) | 7(11.5) | 3(4.9) | 31(4,46) | 24(39.3) |
χ2(Z)值 | 3.540 | 12.034 | 0.212 | 1.615 | 3.195 | -0.157a | 26.081 | |
P值 | 0.060 | 0.001 | 0.733 | 0.289 | 0.109 | 0.875 | <0.001 |
因素 | B | Wald χ2值 | OR值 | 95%CI | P值 |
---|---|---|---|---|---|
胎龄 | 0.253 | 4.211 | 1.288 | (1.011,1.641) | 0.040 |
出生体质量 | -0.001 | 0.001 | 0.999 | (0.998,1.001) | 0.315 |
生后1 min Apgar评分 | 0.019 | 0.028 | 1.019 | (0.815,1.275) | 0.867 |
生后5 min Apgar评分 | 0.771 | 8.579 | 2.162 | (1.291,3.622) | 0.003 |
生后10 min Apgar评分 | -0.330 | 1.519 | 0.719 | (0.426,1.215) | 0.218 |
母亲产前糖皮质激素治疗 | 1.869 | 9.682 | 6.482 | (1.997,21.039) | 0.002 |
Table 5 Multivariate Logistic regression analysis of influencing factors of different NRDS treatment schemes for premature infants
因素 | B | Wald χ2值 | OR值 | 95%CI | P值 |
---|---|---|---|---|---|
胎龄 | 0.253 | 4.211 | 1.288 | (1.011,1.641) | 0.040 |
出生体质量 | -0.001 | 0.001 | 0.999 | (0.998,1.001) | 0.315 |
生后1 min Apgar评分 | 0.019 | 0.028 | 1.019 | (0.815,1.275) | 0.867 |
生后5 min Apgar评分 | 0.771 | 8.579 | 2.162 | (1.291,3.622) | 0.003 |
生后10 min Apgar评分 | -0.330 | 1.519 | 0.719 | (0.426,1.215) | 0.218 |
母亲产前糖皮质激素治疗 | 1.869 | 9.682 | 6.482 | (1.997,21.039) | 0.002 |
[1] |
|
[2] |
邵肖梅,叶鸿瑁,丘小汕. 实用新生儿学[M]. 第5版. 北京:人民卫生出版社,2019.
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
赵捷,杨传忠. 超早产儿发生支气管肺发育不良的影响因素[J]. 中华围产医学杂志,2017,20(11):824-828. DOI:10.3760/cma.j.issn.1007-9408.2017.11.012.
|
[10] |
李帅军,冯琪,童笑梅,等. 超低出生体质量儿复苏及呼吸支持治疗的多中心临床研究[J]. 中华新生儿科杂志,2021,36(2):27-32. DOI:10.3760/cma.j.issn.2096-2932.2021.02.005.
|
[11] |
|
[12] |
|
[13] |
超未成熟儿与超低出生体质量儿研究协作组. 超未成熟儿与超低出生体质量儿产前糖皮质激素使用情况及其对预后影响的多中心调查[J]. 中华围产医学杂志,2020,23(5):302-310. DOI:10.3760/cma.j.cn113903-20190823-00512.
|
[14] |
江苏省NICU母乳喂养质量改进临床研究协作组. 江苏省13家医院极早产儿死亡危险因素分析[J]. 中华新生儿科杂志,2021,36(5):24-29. DOI:10.3760/cma.j.issn.2096-2932.2021.05.006.
|
[15] |
德穷,吴俣,张育彤,等. 西藏藏族孕产妇产前检查次数与低出生体质量儿的关联[J]. 中华疾病控制杂志,2019,23(11):1348-1352. DOI:10.16462/j.cnki.zhjbkz.2019.11.010.
|
[16] |
李才萍. 妊娠期高血压疾病患者终止妊娠时机及分娩方式临床研究[J]. 实用妇科内分泌电子杂志,2017,4(23):64-65. DOI:10.3969/j.issn.2095-8803.2017.23.043.
|
[17] |
|
[18] |
超未成熟儿与超低出生体质量儿研究协作组. 超未成熟儿与超低出生体质量儿临床救治结局分析[J]. 中华新生儿科杂志,2020,35(2):108-112. DOI:10.3760/cma.j.issn.2096-2932.2020.02.008.
|
[19] |
李天浩,林新祝. 早期呼吸支持技术对早产儿神经系统预后的影响[J]. 中华新生儿科杂志,2018,33(5):392-396. DOI:10.3760/cma.j.issn.2096-2932.2018.05.020.
|
[20] |
江苏省新生儿重症监护病房母乳质量改进临床研究协作组. 多中心回顾性分析极低及超低出生体质量儿支气管肺发育不良的临床特点及高危因素[J]. 中华儿科杂志,2019,57(1):33-39. DOI:10.3760/cma.j.issn.0578-1310.2019.01.009.
|
[21] |
董梦园,吉玲,刘萌萌,等. 呼吸窘迫综合征早产儿发生支气管肺发育不良的危险因素分析[J]. 中国儿童保健杂志,2021,29(6):685-688. DOI:10.11852/zgetbjzz2020-2150.
|
[22] |
庄严,高喜容,刘新晖,等. 超早产儿出院时临床结局及影响因素分析[J]. 中华新生儿科杂志,2017,32(2):86-90. DOI:10.3760/cma.j.issn.2096-2932.2017.02.003.
|
[1] | XU Yanpeng, HUANG Pe, ZHANG Pingping, LUO Yan, SHI Xiaoqi, WU Liusong, CHEN Yan, HE Zhixu. Expression of β-Adrenergic Receptors in Acute T-cell Lymphoblastic Leukemia and Its Clinical Significance [J]. Chinese General Practice, 2025, 28(27): 3391-3398. |
[2] | HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin. Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer [J]. Chinese General Practice, 2025, 28(26): 3276-3282. |
[3] | CHOU Xintong, PENG Hanyu, MA Hui, ZHANG Zhen, SU Xian, QIU Hongyan. Maternal Preferences in Contraceptive Decision-making: an Analysis of Influencing Factors [J]. Chinese General Practice, 2025, 28(26): 3294-3299. |
[4] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
[5] | YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le. Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural [J]. Chinese General Practice, 2025, 28(25): 3137-3143. |
[6] | FAN Boyang, ZHANG Yu, SUN Wenning, ZHANG Huifang, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study of Behavioral Intention and Influencing Factors of Integrated Medical and Preventive Care Provided by Grassroots Doctors for Patients with Chronic Diseases [J]. Chinese General Practice, 2025, 28(25): 3144-3150. |
[7] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[8] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[9] | WU Yue, WANG Xuetong, KE Bilian. Evaluation of Vision-related Quality of Life in Myopic Macular Degeneration Patients with Low Vision and Associated Factors [J]. Chinese General Practice, 2025, 28(23): 2908-2914. |
[10] | DING Zijun, ZHOU Nannan, LUO Xing, LUO Jieyu, HAO Wenjuan, ZHANG Chunjiang, JIN Xin, ZHAO Dan. Cognitive Impairment in Patients on Maintenance Hemodialysis and Its Influencing Factors: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2025, 28(23): 2885-2893. |
[11] | CHEN Fei, WANG Jinying, YU Haibo, LI Xin, ZHANG Jiajia, SHEN Man, ZHAN Xiaokai, TANG Ran, FAN Sibin, ZHAO Fengyi, ZHANG Tianyu, HUANG Zhongxia. Significance of Elevated Urinary NGAL, TIM-1, VCAM-1 and Activin A in Patients with New Diagnosed Multiple Myeloma [J]. Chinese General Practice, 2025, 28(22): 2740-2749. |
[12] | WEI Xiaoxia, CHEN Nuo, WANG Juanjuan, ZHU Jingfen. The Effects of Depression and Anxiety on Smoking Behavior among Vocational School Students [J]. Chinese General Practice, 2025, 28(22): 2826-2832. |
[13] | ZHAO Xiaoqing, GUO Tongtong, ZHANG Xinyi, LI Linhong, ZHANG Ya, JI Lihong, DONG Zhiwei, GAO Qianqian, CAI Weiqing, ZHENG Wengui, JING Qi. Construction and Validation of a Risk Prediction Model for Cognitive Impairment in Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(22): 2776-2783. |
[14] | HAO Aihua, ZENG Ziying, JIN Aiqiong, TANG Lingling, ZHENG Zique, MA Jingtai, ZHAO Jianguo, ZENG Weilin, XIAO Jianpeng, NIE Hui, YANG Ying. Analysis of Factors Influencing Avoidable Hospitalization for Elderly Hypertensive Patients [J]. Chinese General Practice, 2025, 28(19): 2370-2375. |
[15] | JING Tao, DAI Yongmei, LUO Jianying, LUO Wei, JI Yelinfan, PENG Chi, ZHANG Cuijun, CAO Yanjun, ZHENG Qing, HUANG Yu, SHEN Hejun. The Body Mass Index, Dietary Knowledge Acquisition Level, Sedentary Time and Influencing Factors among Chinese High School Students [J]. Chinese General Practice, 2025, 28(16): 2025-2032. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||